Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
Lixia Ju(Tongji University), Caicun Zhou(Shanghai Pulmonary Hospital)
Cited by 36
Related Papers
Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer
|Cancer Biomarkers|2013|26
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
|OncoTargets and Therapy|2021|10